Hacker News4d ago

Schizophrenia study finds new biomarker, drug candidate to treat symptoms

https://news.northwestern.edu/stories/2026/03/schizophrenia-study-finds-new-biomarker-drug-candidate-to-treat-cognitive-symptoms

#HackerNews #Schizophrenia #Biomarker #DrugResearch #MentalHealth #Neuroscience

Schizophrenia study finds new biomarker, drug candidate to treat cognitive symptoms

A new Northwestern University study in humans and mice has discovered a novel biomarker of schizophrenia that could also serve as a new drug candidate to treat the cognitive symptoms of the disorder. Schizophrenia affects .5% of the world’s population, including about two million people in the U.S.

NewsrampNov 30
Creative Bioarray launches revolutionary in vitro metabolism assay kits, empowering researchers to accelerate drug development with unprecedented precision and flexibility. #DrugResearch #Biotechnology
N-gated Hacker NewsOct 28
🚀🎉 OMG, someone had the bright idea to map every single off-target effect of FDA-approved drugs! Because who doesn't want to read 6,200 words about drug side effects? 🤯 Thank you, EvE Bio, for providing a comprehensive dataset that only a data scientist could love. 💊📊
https://www.owlposting.com/p/mapping-the-off-target-effects-of #drugresearch #sideeffects #datascience #FDAapproved #healthdata #EvEBio #HackerNews #ngated
Mapping the off-target effects of every FDA-approved drug in existence (EvE Bio)

6.2k words, 29 minutes reading time

Owl Posting
Hacker NewsOct 28

Mapping the off-target effects of every FDA-approved drug in existence

https://www.owlposting.com/p/mapping-the-off-target-effects-of

#HackerNews #Mapping #Drugs #Off-Target #Effects #FDA #Approval #DrugResearch #Healthcare #Innovation

Mapping the off-target effects of every FDA-approved drug in existence (EvE Bio)

6.2k words, 29 minutes reading time

Owl Posting
NonilexOct 4

How #PrivateEquity Oversees the #Ethics of #DrugResearch

Many #DrugTrials are vetted by companies with ties to the #drugmakers, raising concerns about #ConflictsOfInterest & #patient #safety.

#law #PublicHealth
https://www.nytimes.com/2025/10/04/health/drug-trials-ethics-ozempic.html?smid=nytcore-ios-share&referringSource=articleShare

How Private Equity Oversees the Ethics of Drug Research

Many drug trials are vetted by companies with ties to the drugmakers, raising concerns about conflicts of interest and patient safety.

The New York Times
Headlines AfricaMar 20, 2025
Africa: Curing Alzheimer's Disease - Magic Bullet or Magic Shotgun Blast?: [Daily Maverick] Rather than seeking a single cure -- a magic bullet -- for Alzheimer's disease, a shotgun blast of different drugs with different targets may be a better approach to this very complex condition. http://newsfeed.facilit8.network/TJdkJ8 #Alzheimers #Healthcare #DrugResearch #MentalHealth #Neuroscience
PsyPostFeb 3, 2025
Little-known psychedelic drug reduces motivation to take heroin in rats, study finds https://www.psypost.org/little-known-psychedelic-drug-reduces-motivation-to-take-heroin-in-rats-study-finds/?utm_source=dlvr.it&utm_medium=mastodon #Psychedelics #OpioidCrisis #DrugResearch #HeroinAddiction #MentalHealth
Little-known psychedelic drug reduces motivation to take heroin in rats, study finds

Recent research found that the psychedelic drug DOI reduced heroin-seeking behavior in rats by lowering their motivation to obtain heroin. This effect was mediated through 5-HT2A receptors, suggesting DOI’s potential therapeutic role in opioid use disorder treatment.

PsyPost
Larry Felton JohnsonJan 6, 2025

Will AI revolutionize drug development? Researchers explain why it depends on how it’s used #AI #DrugResearch #PharmaceuticalIndustry

This article by Duxin Sun and Christian Macedonia, University of Michigan, first appeared in The Conversation @TheConversationUS , republished with permission

https://cobbcountycourier.com/2025/01/will-ai-revolutionize-drug-development-researchers-explain-why-it-depends-on-how-its-used/

Will AI revolutionize drug development? Researchers explain why it depends on how it’s used

This article by Duxin Sun, University of Michigan, and Christian Macedonia, University of Michigan, first appeared in The Conversation, republished with permission.

Cobb Courier
Ꮆㄖ卩卂ㄥNov 10, 2024
#risdiplam a medicine to treat spinal muscular atrophy (#SMA) cost 72Lakh Indian #Rupee per patient per year (ie. USD85K). Less than 0.1% of Indian households have an annual income of this number. Dr. Melissa Barber of Yale University, reveals the manufacturing cost of this medicine to be less than 3000 INR (ie. USD 35).

This is how private drug research and companies make profit and clearly shows why drug research and production should be in public sphere.
#DrugResearch #DrugPolicy #PublicHealth
timesofindia.indiatimes.com/home/sunday-times/all-that-matters/how-many-patients-must-die-to-pay-the-debt-to-drug-innovation-dr-melissa-barber/articleshow/115122367.cms
How many patients must die to pay the debt to drug innovation: Dr Melissa Barber - Times of India

Sunday Times News: A drug pricing expert reveals the shocking cost disparity of a life-saving spinal muscular atrophy drug in India, priced at Rs 72 lakh per year despit

The Times of India
Dominic TyerApr 24, 2024

European Health Data Space Regulation adopted by European Parliament, marking a key step towards giving people cross-border access to their personal health data

https://www.euractiv.com/section/health-consumers/news/european-health-data-space-clears-the-last-hurdle-in-parliament

#PatientData #EuropeanHealthDataSpace #healthcare #medicine #DrugResearch #pharma #healthdata

European Health Data Space clears the last hurdle in Parliament

The European Parliament adopted on Wednesday (24 April) the European Health Data Space Regulation, a key step

EURACTIV